Nitin Pai was quoted in DW over India’s controversial approval of Covaxin. Nitin stressed that the approval was done for extra-scientific reasons and was therefore likely to be criticized.
He was quoted as saying
It would have been far more honest to admit that there is a strong political imperative to fast-track an indigenous vaccine, and that the regulators have accommodated it while minimizing the risks to the public.
You can read the full article here.
